Cancer cells can manipulate the ECF to evade immune detection and enhance their survival. They achieve this by secreting factors that suppress immune cell function and by altering ECF composition to create a hypoxic and acidic microenvironment, which is often more conducive to cancer cell survival than normal cells. Additionally, cancer cells can induce angiogenesis, the formation of new blood vessels, to improve nutrient and oxygen supply from the ECF.
